Sort
64,565 grants matching “drug discovery”
Cancer Research Center of Hawaii
$1,313,830Michele Carbone · University Of Hawaii At Manoa · P30 · FY2009 · CA
TARGETING OF TUMOR VASCULATURE
$1,313,429Burnham Institute For Medical Research · P01 · FY2000 · CA
Chemoprevention of Skin Cancer Program Project
$1,312,638David S Alberts · University Of Arizona · P01 · FY2015 · CA
Induced Pluripotent Stem Cells in the Understanding and Treatment of Heart Diseas
$1,312,613Deepak Srivastava · J. David Gladstone Institutes · U01 · FY2010 · HL
DNA repair deficient cells for analysis
$1,312,534Jay George · Trevigen, Inc. · R44 · FY2010 · GM
NINDS Human Cell and Data Repository (U24)
$1,312,236Jay Arnold Tischfield · Rutgers, The State Univ Of N.J. · U24 · FY2021 · NS
Innovative technologies to transform antibiotic discovery. Project 4 Infection site-specific amplification of antimicrobial conjugates
$1,312,178Deborah T Hung · Broad Institute, Inc. · U19 · FY2019 · AI
UCSC-Buck Inst. Genome Data Analysis Center for TCGA Research Network (GDAC)
$1,312,129David H Haussler · University Of California Santa Cruz · U24 · FY2011 · CA
Neuroplasticity and cerebral blood flow as key resilience mechanisms in the brains of fast-moving SuperAgers
$1,311,772Jacqueline A Palmer · University Of Minnesota · DP2 · FY2025 · AG
Research Infrastructure Core
$1,311,562Yanyuan Wu · Charles R. Drew University Of Med & Sci · U54 · FY2020 · MD
1/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership
$1,311,431Victoria L. Seewaldt · Beckman Research Institute/City Of Hope · U54 · FY2024 · CA
MCSP TORFP NO. NIH-NINDS-21-01: FLORIO (ANAGIN) - BASE EC (STROKE)
$1,311,329Melissa Allard · Albany Molecular Research, Inc. · N01 · FY2022 · DA
HIT TO LEAD CHEMISTRY UNDER PERFORMANCE AREA 2 OF ID/IQ CONTRACT NO. HHSN271201800001I
$1,311,322Keith Barnes · Albany Molecular Research, Inc. · N01 · FY2022 · DA
SBIR Phase II: Serendipitous Search System Using Lateral Analogy to Match Potential Solutions to Unmet Needs:Feasibility Study Based on Screening Approved Drugs for Repurposing
$1,310,747Brian M Sager · Leonardo Innovations Inc. · · FY2014 · TIP
Signaling Aberrations and Cerebral Cavernous Malformation Pathogenesis
$1,310,712Douglas A Marchuk · Duke University · P01 · FY2021 · NS
MAP4K3 regulation of cellular stress response pathways in health and disease
$1,310,665Albert R La Spada · University Of California-Irvine · RF1 · FY2025 · AG
Translational studies for identifying and targeting novel pathways in systemic sclerosis pathogenesis
$1,310,592Robert A Lafyatis · University Of Pittsburgh At Pittsburgh · P50 · FY2018 · AR
Molecular Definition of Brain Circuits Controlling Addiction
$1,310,547Nathaniel Heintz · Rockefeller University · P30 · FY2015 · DA
Narcotic Drug and Opioid Peptide Basic Research project
$1,310,342University Of Michigan At Ann Arbor · P01 · FY2005 · DA
UCSC-Buck Inst. Genome Data Analysis Center for TCGA Research Network (GDAC)
$1,309,530David H Haussler · University Of California Santa Cruz · U24 · FY2012 · CA
Dietary Biomarkers Development Center at Harvard University
$1,309,356Frank B Hu · Harvard University D/B/A Harvard School Of Public Health · U2C · FY2025 · DK
Translational studies for identifying and targeting novel pathways in systemic sclerosis pathogenesis
$1,309,324Robert A Lafyatis · University Of Pittsburgh At Pittsburgh · P50 · FY2017 · AR
Psoriasis Center of Research Translation
$1,308,373Kevin D Cooper · Case Western Reserve University · P50 · FY2019 · AR
Accelerated Discovery and Development of New Pain Therapeutics
$1,308,367Tage Honore · Aestus Therapeutics, Inc. · R44 · FY2011 · NS
Psoriasis Center of Research Translation
$1,308,288Kevin D Cooper · Case Western Reserve University · P50 · FY2021 · AR